Literature DB >> 14699489

CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration.

Jon D Vogel1, Gail A West, Silvio Danese, Carol De La Motte, Manijeh H Phillips, Scott A Strong, Joseph Willis, Claudio Fiocchi.   

Abstract

BACKGROUND AND AIMS: The CD40 pathway is a key mediator of inflammation and autoimmunity. We investigated cell adhesion molecule (CAM) up-regulation and chemokine production by CD40-positive human intestinal fibroblasts (HIF) and microvascular endothelial cells (HIMEC) induced by CD40 ligand (CD40L)-positive T cells and soluble CD40L and their effect on T-cell adhesion and transmigration.
METHODS: Expression of CD40, CD40L, and CAM was assessed by immunohistochemistry, confocal microscopy and flow cytometric analysis, and chemokine production using enzyme-linked immunosorbent assay. Calcein-labeled T cells were used to assay HIF adhesion and Transwell HIMEC transmigration.
RESULTS: Ligation of CD40-positive HIF and HIMEC by CD40L-positive T cells or soluble CD40L induced up-regulation of CAM expression as well as interleukin-8 and RANTES production. The specificity of these responses was shown by inhibition with a CD40L blocking antibody and by CD40 signaling-dependent p38 mitogen-activated protein kinase phosphorylation. On CD40 ligation, HIF increased their T-cell binding capacity and generated chemoattractants able to induce T-cell migration through HIMEC monolayers.
CONCLUSIONS: Activation of the CD40/CD40L system in the gut mucosa may trigger a self-sustaining loop of immune-nonimmune cell interactions leading to an antigen-independent influx of T cells that contributes to chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14699489     DOI: 10.1053/j.gastro.2003.10.046

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

Review 1.  The CD40/CD40L costimulatory pathway in inflammatory bowel disease.

Authors:  S Danese; M Sans; C Fiocchi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

2.  CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  Mol Immunol       Date:  2010-06-19       Impact factor: 4.407

3.  Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis.

Authors:  Lino Polese; Imerio Angriman; De Franchis Giuseppe; Attilio Cecchetto; Giacomo-C Sturniolo; D'Inca Renata; Marco Scarpa; Cesare Ruffolo; Lorenzo Norberto; Mauro Frego; Davide-F D'Amico
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

4.  CD40 antisense based strategy for inflammatory bowel disease: shutting down multiple cellular communication systems.

Authors:  S Danese; M Sans; A Gasbarrini
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

5.  Proinflammatory cytokine synthesis by mucosal fibroblasts from mouse colitis is enhanced by interferon-gamma-mediated up-regulation of CD40 signalling.

Authors:  T De L Karlson; C V Whiting; P W Bland
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

6.  Platelet hyaluronidase-2 regulates the early stages of inflammatory disease in colitis.

Authors:  Aaron C Petrey; Dana R Obery; Sean P Kessler; Ash Zawerton; Bruno Flamion; Carol A de la Motte
Journal:  Blood       Date:  2019-07-01       Impact factor: 22.113

7.  Tumour necrosis factor-alpha production stimulated by heat shock protein 70 and its inhibition in circulating dendritic cells and cells eluted from mucosal tissues in Crohn's disease.

Authors:  T Whittall; Y Wang; C G Kelly; R Thompson; J Sanderson; M Lomer; S Y Soon; L A Bergmeier; M Singh; T Lehner
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

8.  Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease.

Authors:  D C Baumgart; S Thomas; I Przesdzing; D Metzke; C Bielecki; S M Lehmann; S Lehnardt; Y Dörffel; A Sturm; A Scheffold; J Schmitz; A Radbruch
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

Review 9.  Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.

Authors:  Florian Rieder; Piero Biancani; Karen Harnett; Lisa Yerian; Gary W Falk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

10.  Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction.

Authors:  Bodil Ohlsson; Eva Ekblad; Béla Veress; Agneta Montgomery; Sabina Janciauskiene
Journal:  BMC Gastroenterol       Date:  2010-05-20       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.